Detalhe da pesquisa
1.
Capivasertib combines with docetaxel to enhance anti-tumour activity through inhibition of AKT-mediated survival mechanisms in prostate cancer.
Br J Cancer
; 130(8): 1377-1387, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38396173
2.
Renal differentiation from adult spermatogonial stem cells.
Ren Fail
; 35(10): 1387-91, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23991628
3.
Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.
NPJ Breast Cancer
; 9(1): 64, 2023 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37543694
4.
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance.
Cancer Res
; 83(23): 3989-4004, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725704
5.
Lineage Plasticity in SCLC Generates Non-Neuroendocrine Cells Primed for Vasculogenic Mimicry.
J Thorac Oncol
; 18(10): 1362-1385, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37455012
6.
In situ lineage tracking of human prostatic epithelial stem cell fate reveals a common clonal origin for basal and luminal cells.
J Pathol
; 225(2): 181-8, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21898876
7.
VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status.
J Hematol Oncol
; 14(1): 186, 2021 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34742344
8.
The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer.
Cancer Res
; 80(6): 1293-1303, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31969375
9.
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.
NPJ Breast Cancer
; 9(1): 76, 2023 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726304
10.
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.
NPJ Breast Cancer
; 9(1): 69, 2023 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596288
11.
Multipotent Basal Stem Cells, Maintained in Localized Proximal Niches, Support Directed Long-Ranging Epithelial Flows in Human Prostates.
Cell Rep
; 20(7): 1609-1622, 2017 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28813673
12.
Vasculogenic mimicry in small cell lung cancer.
Nat Commun
; 7: 13322, 2016 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27827359
13.
A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
Eur Urol
; 64(5): 753-61, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23582880
14.
Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling.
PLoS One
; 7(11): e50690, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23226356
15.
Human α(2)ß(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.
PLoS One
; 7(11): e48944, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23145034